Stage IV Adult Immunoblastic Large Cell Lymphoma Completed Phase 1 Trials for Capecitabine (DB01101)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028715 (Stage IV Adult Immunoblastic Large Cell Lymphoma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | Treatment |